ENTA

ENANTA PHARMACEUTICALS INC

ENTA·29251M106·US·Common Stock·Healthcare - Biotechnology-13D/G

ENTA (ENANTA PHARMACEUTICALS INC) is held by 75 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($47.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($35.3M), VANGUARD CAPITAL MANAGEMENT LLC ($17.7M). Net institutional sentiment: Mixed.

75
Holders
(5 Elite)
$213.4M
Total Value
58% (72)
Consensus
42 buying - 30 selling
13F: Insider & Congress: Updated regularly
ENTA

Smart Money Verdict

View all
Loading verdict
Held by 75 funds
5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 10, 2026 · Activists Aug 14, 2026 · Congress none

ActivistFarallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.8.3%Aug 14, 2026
ActivistDTDeep Track Capital, LP5.0%Aug 14, 2026
InsiderRTRottinghaus Scott T.Tax 1K shAug 8, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.2M(+4.5%)$47.3M0.0%+39.34%
31
Decreased
2.4M(-15.8%)$35.3M0.2%-66.36%
0
Increased
1.2M(+2.9%)$17.7M0.0%-3.85%
29
Increased
1M(+6.6%)$14.7M0.0%-3.82%
30
Increased
776,634(+7.1%)$11.3M0.0%-61.92%
30
Decreased
643,967(-27.0%)$9.4M0.0%+17.59%
0
Increased
576,117(+2.5%)$8.4M0.0%+36.02%
28
Decreased
557,600(-16.2%)$8.1M0.0%-60.68%
0
Increased
464,649(+75.3%)$6.8M0.0%+12.11%
41
Increased
315,729(+2.0%)$4.6M0.0%+9.51%
27
Increased
301,151(+2.1%)$4.4M0.0%-61.91%
27
Increased
282,682(+39.1%)$4.1M0.0%-25.68%
35
Increased
259,696(+7.8%)$3.8M0.0%-69.63%
29
Decreased
256,870(-18.0%)$3.7M0.0%+59.28%
0
Increased
185,618(+5.5%)$2.7M0.0%-3.82%
28
Increased
153,008(+21.7%)$2.2M0.0%-1.57%
31
Increased
150,546(+5773.8%)$2.2M0.0%-2.99%
42
Decreased
131,995(-37.2%)$1.9M0.0%-12.98%
0
Decreased
96,764(-6.1%)$1.4M0.0%+37.96%
0
Increased
84,231(+15.6%)$1.2M0.0%-27.23%
29

Showing 1-20 of 81

1 / 5
ENTAENTAENANTA PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used